| Application number | Title of the application | Filing Date | Status |
|---|
Array
(
[id] => 18476580
[patent_doc_number] => RE049569
[patent_country] => US
[patent_kind] => E1
[patent_issue_date] => 2023-07-04
[patent_title] => Alkylamine derivative
[patent_app_type] => reissue
[patent_app_number] => 17/220471
[patent_app_country] => US
[patent_app_date] => 2021-04-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 8
[patent_no_of_words] => 22513
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 12
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17220471
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/220471 | Alkylamine derivative | Mar 31, 2021 | Issued |
| 17/194645 | Process For Producing Acesulfame Potassium | Mar 7, 2021 | Pending |
| 17/193965 | COMPOUNDS, COMPOSITIONS AND METHODS USEFUL FOR CHOLESTEROL MOBILIZATION | Mar 4, 2021 | Abandoned |
Array
(
[id] => 18699387
[patent_doc_number] => RE049700
[patent_country] => US
[patent_kind] => E1
[patent_issue_date] => 2023-10-17
[patent_title] => Substituted nitrogen containing compounds
[patent_app_type] => reissue
[patent_app_number] => 17/183286
[patent_app_country] => US
[patent_app_date] => 2021-02-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 101402
[patent_no_of_claims] => 61
[patent_no_of_ind_claims] => 13
[patent_words_short_claim] => 7
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17183286
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/183286 | Substituted nitrogen containing compounds | Feb 22, 2021 | Issued |
Array
(
[id] => 18799390
[patent_doc_number] => RE049742
[patent_country] => US
[patent_kind] => E1
[patent_issue_date] => 2023-12-05
[patent_title] => Drug delivery system for administration of poorly water soluble pharmaceutically active substances
[patent_app_type] => reissue
[patent_app_number] => 17/177550
[patent_app_country] => US
[patent_app_date] => 2021-02-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 10
[patent_no_of_words] => 12162
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => -2
[patent_words_short_claim] => 87
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17177550
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/177550 | Drug delivery system for administration of poorly water soluble pharmaceutically active substances | Feb 16, 2021 | Issued |
| 17/177544 | DRUG DELIVERY SYSTEM FOR ADMINISTRATION OF POORLY WATER SOLUBLE PHARMACEUTICALLY ACTIVE SUBSTANCES | Feb 16, 2021 | Abandoned |
| 17/175078 | METHODS AND COMPOSITIONS FOR IMPROVING COGNITIVE FUNCTION | Feb 11, 2021 | Abandoned |
Array
(
[id] => 18683223
[patent_doc_number] => RE049687
[patent_country] => US
[patent_kind] => E1
[patent_issue_date] => 2023-10-10
[patent_title] => Thienopyrimidine and thienopyridine compounds and methods of use thereof
[patent_app_type] => reissue
[patent_app_number] => 17/165794
[patent_app_country] => US
[patent_app_date] => 2021-02-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 64794
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 9
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17165794
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/165794 | Thienopyrimidine and thienopyridine compounds and methods of use thereof | Feb 1, 2021 | Issued |
| 17/152120 | INHIBITION OF MK2 IN THE TREATMENT OF CANCER | Jan 18, 2021 | Abandoned |
Array
(
[id] => 18502988
[patent_doc_number] => RE049582
[patent_country] => US
[patent_kind] => E1
[patent_issue_date] => 2023-07-18
[patent_title] => Therapeutic compounds and compositions
[patent_app_type] => reissue
[patent_app_number] => 17/131562
[patent_app_country] => US
[patent_app_date] => 2020-12-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 70
[patent_figures_cnt] => 70
[patent_no_of_words] => 60615
[patent_no_of_claims] => 57
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 8
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17131562
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/131562 | Therapeutic compounds and compositions | Dec 21, 2020 | Issued |
| 90/014599 | PROCESS FOR PREPARING CYCLOPHOSPHAMIDE, INTERMEDIATES, AND MONOHYDRATE THEREOF | Dec 16, 2020 | Issued |
Array
(
[id] => 18699384
[patent_doc_number] => RE049697
[patent_country] => US
[patent_kind] => E1
[patent_issue_date] => 2023-10-17
[patent_title] => Crystalline N-[5-(aminosulfonyl)-4-methyl-1,3-thiazol-2-yl]-N-methyl-2-[4-(2-pyridinyl)phenyl]acetamide mono mesylate monohydrate having a specific particle size distribution range and a specific surface area range for use in pharmaceutical formulations
[patent_app_type] => reissue
[patent_app_number] => 17/104028
[patent_app_country] => US
[patent_app_date] => 2020-11-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 15
[patent_no_of_words] => 19054
[patent_no_of_claims] => 32
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 74
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17104028
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/104028 | Crystalline N-[5-(aminosulfonyl)-4-methyl-1,3-thiazol-2-yl]-N-methyl-2-[4-(2-pyridinyl)phenyl]acetamide mono mesylate monohydrate having a specific particle size distribution range and a specific surface area range for use in pharmaceutical formulations | Nov 24, 2020 | Issued |
Array
(
[id] => 19011027
[patent_doc_number] => RE049860
[patent_country] => US
[patent_kind] => E1
[patent_issue_date] => 2024-03-05
[patent_title] => Process for preparing (4S)-4-(4-cyano-2-methoxyphenyl)-5-ethoxy-2,8-dimethyl-1,4-dihydro-1,6-naphthyridine-3-carboxamide and purification thereof for use as pharmaceutical active ingredient
[patent_app_type] => reissue
[patent_app_number] => 17/087659
[patent_app_country] => US
[patent_app_date] => 2020-11-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 13964
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 44
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17087659
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/087659 | Process for preparing (4S)-4-(4-cyano-2-methoxyphenyl)-5-ethoxy-2,8-dimethyl-1,4-dihydro-1,6-naphthyridine-3-carboxamide and purification thereof for use as pharmaceutical active ingredient | Nov 2, 2020 | Issued |
Array
(
[id] => 18683222
[patent_doc_number] => RE049686
[patent_country] => US
[patent_kind] => E1
[patent_issue_date] => 2023-10-10
[patent_title] => Nitrogen-containing heterocyclic compound and use of same
[patent_app_type] => reissue
[patent_app_number] => 17/076227
[patent_app_country] => US
[patent_app_date] => 2020-10-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 70750
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17076227
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/076227 | Nitrogen-containing heterocyclic compound and use of same | Oct 20, 2020 | Issued |
Array
(
[id] => 18618463
[patent_doc_number] => RE049647
[patent_country] => US
[patent_kind] => E1
[patent_issue_date] => 2023-09-12
[patent_title] => Formulations of (S)-3-(4-((4-(morpholinomethyl)benzyl)oxy)-1-oxoisoindolin-2-yl)piperidine-2,6-dione
[patent_app_type] => reissue
[patent_app_number] => 17/030272
[patent_app_country] => US
[patent_app_date] => 2020-09-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 24797
[patent_no_of_claims] => 37
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 128
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17030272
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/030272 | Formulations of (S)-3-(4-((4-(morpholinomethyl)benzyl)oxy)-1-oxoisoindolin-2-yl)piperidine-2,6-dione | Sep 22, 2020 | Issued |
Array
(
[id] => 18426994
[patent_doc_number] => RE049551
[patent_country] => US
[patent_kind] => E1
[patent_issue_date] => 2023-06-13
[patent_title] => Heterogeneous catalyst for transesterification and method of preparing same
[patent_app_type] => reissue
[patent_app_number] => 17/019691
[patent_app_country] => US
[patent_app_date] => 2020-09-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 3322
[patent_no_of_claims] => 1
[patent_no_of_ind_claims] => -6
[patent_words_short_claim] => 97
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17019691
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/019691 | Heterogeneous catalyst for transesterification and method of preparing same | Sep 13, 2020 | Issued |
Array
(
[id] => 18558074
[patent_doc_number] => RE049610
[patent_country] => US
[patent_kind] => E1
[patent_issue_date] => 2023-08-15
[patent_title] => Heterogeneous catalyst for transesterification and method of preparing same
[patent_app_type] => reissue
[patent_app_number] => 17/019903
[patent_app_country] => US
[patent_app_date] => 2020-09-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 3334
[patent_no_of_claims] => 1
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 106
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17019903
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/019903 | Heterogeneous catalyst for transesterification and method of preparing same | Sep 13, 2020 | Issued |
Array
(
[id] => 18100564
[patent_doc_number] => RE049352
[patent_country] => US
[patent_kind] => E1
[patent_issue_date] => 2023-01-03
[patent_title] => Carbamoyloxymethyl triazole cyclohexyl acids as LPA antagonists
[patent_app_type] => reissue
[patent_app_number] => 17/011592
[patent_app_country] => US
[patent_app_date] => 2020-09-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 66591
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 14
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17011592
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/011592 | Carbamoyloxymethyl triazole cyclohexyl acids as LPA antagonists | Sep 2, 2020 | Issued |
Array
(
[id] => 18443045
[patent_doc_number] => RE049555
[patent_country] => US
[patent_kind] => E1
[patent_issue_date] => 2023-06-20
[patent_title] => Process for producing a stable low concentration, injectable solution of noradrenaline
[patent_app_type] => reissue
[patent_app_number] => 17/006841
[patent_app_country] => US
[patent_app_date] => 2020-08-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3618
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => -1
[patent_words_short_claim] => 63
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17006841
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/006841 | Process for producing a stable low concentration, injectable solution of noradrenaline | Aug 29, 2020 | Issued |
| 90/014565 | SOLVENT SYSTEMS FOR DICYANDIAMIDE AND/OR ALKYL THIOPHOSPHORIC TRIAMIDE AND USE IN AGRICULTURAL APPLICATIONS | Aug 25, 2020 | Issued |